PharmaShots | Incisive News in 3 Shots

Subscribe Now

Eucure

Eucure Subsidiary Biocytogen Entered into a Worldwide License Agreement with Syncromune for the Development and Commercialization of Intratumoral Immunotherapy

Eucure Subsidiary Biocytogen Entered into a Worldwide License Agreement with Syncromune for the Development and Commercialization...

October 18, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us